{"id":51058,"date":"2025-07-27T00:38:27","date_gmt":"2025-07-27T04:38:27","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/neuralink-ventures-into-bionic-eye-development-with-new-clinical-trial\/51058\/"},"modified":"2025-07-27T00:38:27","modified_gmt":"2025-07-27T04:38:27","slug":"neuralink-ventures-into-bionic-eye-development-with-new-clinical-trial","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/neuralink-ventures-into-bionic-eye-development-with-new-clinical-trial\/51058\/","title":{"rendered":"Neuralink Ventures into Bionic Eye Development with New Clinical Trial"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Neuralink<\/strong>, the neurotechnology company co-founded by <strong>Elon Musk<\/strong>, has joined a clinical trial aimed at developing an &quot;AI-powered artificial vision&quot; system, commonly referred to as a &quot;Smart Bionic Eye,&quot; to restore vision in individuals with blindness.<\/li>\n<li>The study, sponsored by the <strong>University of California, Santa Barbara (UCSB)<\/strong>, is designed to address fundamental questions crucial for the development of such an advanced visual prosthesis.<\/li>\n<li>This collaboration marks a significant expansion of <strong>Neuralink&#39;s<\/strong> clinical research beyond its current brain-computer interface (BCI) trials for paralysis, signaling a new frontier in its efforts to apply its technology to sensory restoration.<\/li>\n<\/ul>\n<p><strong>Neuralink<\/strong>, the brain implant company backed by <strong>Elon Musk<\/strong>, has entered a new clinical trial focusing on the development of a &quot;bionic eye&quot; to restore vision. The trial, publicly disclosed in late July on ClinicalTrials.gov, is a collaborative effort with researchers from the <strong>University of California, Santa Barbara<\/strong> and a Spanish university, <strong>Universidad Miguel Hern\u00e1ndez de Elche<\/strong>.<\/p>\n<p>The primary objective of the study is to explore how brain-computer interfaces can help blind patients regain sight using artificial intelligence. Researchers envision an AI-powered device that would enable blind individuals to recognize faces, navigate outdoors, and read. This initiative represents a notable expansion of <strong>Neuralink&#39;s<\/strong> clinical research activities, moving into the realm of sensory restoration.<\/p>\n<p>While <strong>Neuralink<\/strong> is currently conducting other U.S.-based clinical trials, PRIME and CONVOY, which focus on its brain-computer interface for patients with limb paralysis, this new &quot;bionic eye&quot; study is distinct. The trial is currently enrolling patients by invitation only, with the study description indicating that <strong>Neuralink<\/strong> patients will be included &quot;once available.&quot;<\/p>\n<p>The project aligns with <strong>Neuralink&#39;s<\/strong> broader roadmap, which includes the <strong>Blindsight<\/strong> vision chip. This chip, which has only been tested in monkeys so far, aims to restore vision in people with blindness. <strong>Musk<\/strong> has previously stated that <strong>Neuralink<\/strong> intends to implant <strong>Blindsight<\/strong> in a human for the first time later this year. The company projects that <strong>Blindsight<\/strong> and other implant projects could generate <strong>$1 billion<\/strong> in annual revenue by <strong>2031<\/strong>.<\/p>\n<p>The collaboration leverages <strong>Neuralink&#39;s<\/strong> expertise in ultra-thin electrodes and wireless communication systems, which are integral to interfacing with retinal or cortical implants to bypass damaged optical pathways. Researchers in California are concentrating on device testing, while Spanish teams contribute their knowledge in neuro-ophthalmology. This cross-border partnership could potentially streamline international approvals and accelerate innovation in the field of medical technology.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Neuralink, the neurotechnology company co-founded by Elon Musk, has joined a clinical trial aimed at developing an &quot;AI-powered [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[6897,3703,5832,6016,6845,6892,6893,6894,6895,6896],"class_list":["post-51058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-ucsb","tag-ai","tag-bci","tag-biotechnology","tag-neuralink","tag-bionic-eye","tag-clinical-trial","tag-neurotechnology","tag-vision-restoration","tag-n-a"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/51058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=51058"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/51058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=51058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=51058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=51058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}